Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer

Abstract Background Helicobacter pylori is a gastric pathogen that is responsible for causing chronic inflammation and increasing the risk of gastric cancer development. It is capable of persisting for decades in the harsh gastric environment because of the inability of the host to eradicate the inf...

Full description

Bibliographic Details
Main Authors: Mahjerin Nasrin Reza, Shahin Mahmud, Nadim Ferdous, Ishtiaque Ahammad, Mohammad Uzzal Hossain, Md. Al Amin, A. K. M. Mohiuddin
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.6772
_version_ 1797371939661021184
author Mahjerin Nasrin Reza
Shahin Mahmud
Nadim Ferdous
Ishtiaque Ahammad
Mohammad Uzzal Hossain
Md. Al Amin
A. K. M. Mohiuddin
author_facet Mahjerin Nasrin Reza
Shahin Mahmud
Nadim Ferdous
Ishtiaque Ahammad
Mohammad Uzzal Hossain
Md. Al Amin
A. K. M. Mohiuddin
author_sort Mahjerin Nasrin Reza
collection DOAJ
description Abstract Background Helicobacter pylori is a gastric pathogen that is responsible for causing chronic inflammation and increasing the risk of gastric cancer development. It is capable of persisting for decades in the harsh gastric environment because of the inability of the host to eradicate the infection. Several treatment strategies have been developed against this bacterium using different antibiotics. But the effectiveness of treating H. pylori has significantly decreased due to widespread antibiotic resistance, including an increased risk of gastric cancer. The small interfering RNAs (siRNA), which is capable of sequence‐specific gene‐silencing can be used as a new therapeutic approach for the treatment of a variety of such malignancies. In the current study, we rationally designed two siRNA molecules to silence the cytotoxin‐associated gene A (CagA) and vacuolating cytotoxin A (VacA) genes of H. pylori for their significant involvement in developing cancer. Methods We selected a common region of all the available transcripts from different countries of CagA and VacA to design the siRNA molecules. The final siRNA candidate was selected based on the results from machine learning algorithms, off‐target similarity, and various thermodynamic properties. Result Further, we utilized molecular docking and all atom molecular dynamics (MD) simulations to assess the binding interactions of the designed siRNAs with the major components of the RNA‐induced silencing complex (RISC) and results revealed the ability of the designed siRNAs to interact with the proteins of RISC complex in comparable to those of the experimentally reported siRNAs. Conclusion These designed siRNAs should effectively silence the CagA and VacA genes of H. pylori during siRNA mediated treatment in gastric cancer.
first_indexed 2024-03-08T18:28:04Z
format Article
id doaj.art-c670455cee6d4007b7a03285db97f45d
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-03-08T18:28:04Z
publishDate 2023-12-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-c670455cee6d4007b7a03285db97f45d2023-12-30T08:53:26ZengWileyCancer Medicine2045-76342023-12-011224224072241910.1002/cam4.6772Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancerMahjerin Nasrin Reza0Shahin Mahmud1Nadim Ferdous2Ishtiaque Ahammad3Mohammad Uzzal Hossain4Md. Al Amin5A. K. M. Mohiuddin6Department of Biotechnology and Genetic Engineering, Life Science Faculty Mawlana Bhashani Science and Technology University Tangail BangladeshDepartment of Biotechnology and Genetic Engineering, Life Science Faculty Mawlana Bhashani Science and Technology University Tangail BangladeshDepartment of Biotechnology and Genetic Engineering, Life Science Faculty Mawlana Bhashani Science and Technology University Tangail BangladeshBioinformatics Division National Institute of Biotechnology Ashulia BangladeshBioinformatics Division National Institute of Biotechnology Ashulia BangladeshDepartment of Biotechnology and Genetic Engineering, Life Science Faculty Mawlana Bhashani Science and Technology University Tangail BangladeshDepartment of Biotechnology and Genetic Engineering, Life Science Faculty Mawlana Bhashani Science and Technology University Tangail BangladeshAbstract Background Helicobacter pylori is a gastric pathogen that is responsible for causing chronic inflammation and increasing the risk of gastric cancer development. It is capable of persisting for decades in the harsh gastric environment because of the inability of the host to eradicate the infection. Several treatment strategies have been developed against this bacterium using different antibiotics. But the effectiveness of treating H. pylori has significantly decreased due to widespread antibiotic resistance, including an increased risk of gastric cancer. The small interfering RNAs (siRNA), which is capable of sequence‐specific gene‐silencing can be used as a new therapeutic approach for the treatment of a variety of such malignancies. In the current study, we rationally designed two siRNA molecules to silence the cytotoxin‐associated gene A (CagA) and vacuolating cytotoxin A (VacA) genes of H. pylori for their significant involvement in developing cancer. Methods We selected a common region of all the available transcripts from different countries of CagA and VacA to design the siRNA molecules. The final siRNA candidate was selected based on the results from machine learning algorithms, off‐target similarity, and various thermodynamic properties. Result Further, we utilized molecular docking and all atom molecular dynamics (MD) simulations to assess the binding interactions of the designed siRNAs with the major components of the RNA‐induced silencing complex (RISC) and results revealed the ability of the designed siRNAs to interact with the proteins of RISC complex in comparable to those of the experimentally reported siRNAs. Conclusion These designed siRNAs should effectively silence the CagA and VacA genes of H. pylori during siRNA mediated treatment in gastric cancer.https://doi.org/10.1002/cam4.6772CagA and VacAgastric cancerHelicobacter pylorisiRNA
spellingShingle Mahjerin Nasrin Reza
Shahin Mahmud
Nadim Ferdous
Ishtiaque Ahammad
Mohammad Uzzal Hossain
Md. Al Amin
A. K. M. Mohiuddin
Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer
Cancer Medicine
CagA and VacA
gastric cancer
Helicobacter pylori
siRNA
title Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer
title_full Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer
title_fullStr Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer
title_full_unstemmed Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer
title_short Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer
title_sort gene silencing of helicobacter pylori through newly designed sirna convenes the treatment of gastric cancer
topic CagA and VacA
gastric cancer
Helicobacter pylori
siRNA
url https://doi.org/10.1002/cam4.6772
work_keys_str_mv AT mahjerinnasrinreza genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer
AT shahinmahmud genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer
AT nadimferdous genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer
AT ishtiaqueahammad genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer
AT mohammaduzzalhossain genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer
AT mdalamin genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer
AT akmmohiuddin genesilencingofhelicobacterpylorithroughnewlydesignedsirnaconvenesthetreatmentofgastriccancer